drugset / Trial / NCT07596173

A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years

NCT07596173 ↗

Phase 3 Recruiting 85 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of the study is to assess the immune response, reactogenicity and safety of a booster dose of dTpa vaccine 1 month after vaccination in healthy Japanese participants aged 11 to \<13 years.

Timeline

Start
2026-06-29
Primary completion
2026-10-14
Completion
2026-10-14

Drugs

EvaluationDrugModalityDoseRoute
Subject dTpa vaccine Vaccine — —

Indications

No indication recorded.